Variable | Blood Pressure | COR (95 %CI) | AOR (95 %CI) | ||
---|---|---|---|---|---|
Controlled | Uncontrolled | ||||
Age category | <50Â years | 20 | 44 | 1.00 | 1.00 |
≥ 50 years | 37 | 30 | 2.55 (1.72, 4.75)* | 2.06 (2.65, 7.79)* | |
Gender | Male | 33 | 34 | 1.00 | 1.00 |
Female | 24 | 40 | 1. 63 (0. 98, 2. 90)* | 1.42 (1.19, 2.14)* | |
Marital status | Married | 45 | 64 | 1.00 | 1.00 |
Single | 7 | 4 | 2.721 (10.59, 13.36) | 3.42 (11.22, 14.12) | |
Divorced | 2 | 2 | 0.55 (0.14, 5.53) | 0.49 (0.54, 1. 59) | |
Widowed | 3 | 4 | 1.46 (0.22, 0.78)* | 1.76 (0.46, 1.27) | |
Education level | No formal education | 7 | 28 | 1.00 | 1.00 |
Primary | 12 | 21 | 2.22 (1.80, 2.84) | 0. 18 (0. 15, 1. 13) | |
Secondary | 15 | 12 | 1. 15 (0. 98, 2. 35) | 0. 07 (0.37, 1. 53) | |
Tertiary and above | 23 | 13 | 0. 27 (0. 34, 1. 12)* | 0. 62 (0. 31, 0. 45)* | |
Residence | Rural | 18 | 22 | 1.00 | 1.00 |
Urban | 39 | 52 | 0. 28 (1. 34, 11. 75) | 2.11 (2.47, 9.16) | |
Monthly income (ETB) | No regular income | 15 | 26 | 2.17 (4.42, 6.15) | 1.23 (0.23, 4.74) |
<1000 | 6 | 15 | 1.06 (1.24, 3.1 5) | 1.09 (2.12, 6.11) | |
1000–2000 | 9 | 10 | 0.69 (1.79, 3.35) | 0.453 (0.32, 7.42) | |
2000–3000 | 7 | 11 | 0.66 (0. 64, 5. 59) | 0.23 (2.32, 9.47) | |
≥ 3000 | 20 | 12 | 1.00 | 1.00 | |
Occupation | Gov’t employee | 21 | 9 | 1.00 | 1.00 |
Non-Gov’t employee | 13 | 6 | 0. 28 (0. 34, 1. 75) | 1. 10 (0. 74, 2. 61) | |
Self employed | 9 | 29 | 0.67 (0.27, 1.66) | 0.68 (0.25, 1.87) | |
Unemployed | 14 | 30 | 1.06 (0.60, 1.85) | 1.05 (0.57, 1.94) | |
Smoking | No | 52 | 58 | 1.00 | 1.00 |
Yes | 5 | 16 | 1.31 (0.75, 2.28)* | 1.14 (0.62, 2.10) | |
Alcohol intake | No | 53 | 55 | 1.00 | 1.00 |
Yes | 4 | 19 | 1.66 (0.46, 5.95)* | 1.23 (0.32, 4.74) | |
Chat chewer | No | 42 | 53 | 1.00 | 1.00 |
Yes | 15 | 21 | 1.05 (0.67, 1.66) | 1.12 (0.68, 1.84) | |
Adherence | Adherent | 49 | 48 | 1.00 | 1.00 |
Non-adherent | 8 | 26 | 2. 37 (2.71, 8. 65)* | 2.05 (2.61, 9.33)* | |
Frequency of follow up | Monthly | 40 | 31 | 0. 35 (0. 53, 0. 97)* | 0. 65 (0. 63, 0. 98)* |
Every 2Â months | 10 | 31 | 1.31 (0.75, 2.28) | 1. 4 2 (2. 26, 3.01) | |
Every 3Â months | 7 | 12 | 1.00 | 1.00 | |
Duration with Hypertension | ≤ 1 year | 13 | 12 | 1.00 | 1.00 |
2–5 years | 20 | 25 | 0. 69 (1. 36, 11.44) | 1.11 (2.62, 6.63) | |
≥ 5 years | 24 | 37 | 1. 75 (1. 59, 5. 85)* | 2.88 (1.27, 8.31)* | |
Blood Sugar | Controlled | 51 | 35 | 1.00 | 1.00 |
Uncontrolled | 6 | 39 | 2.33 (2. 11, 7. 15)* | 1. 65 (2. 14,3. 32)* | |
Comorbidity | No | 40 | 48 | 1.00 | 1.00 |
Yes | 17 | 26 | 1.04 (0. 44, 3. 31)* | 1.12 (1. 22, 4. 45) | |
Anti-HTN regimen | Monotherapy | 13 | 18 | 1.00 | 1.00 |
Dual Therapy | 40 | 49 | 048 (0.13, 1.08) | 0.44 (1.10, 2.11) | |
Triple therapy | 4 | 7 | 1.35 (1.79, 4.78) | 1.68 (1.19, 3.43) |